Delivery Order SPE2DB20D3103-SPE2DB25FQ1G2
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $29,807.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for JEMPERLI 500 mg/10 mL vials on May 20, 2025, with a completion date of June 11, 2025. JEMPERLI (venetoclax) is a targeted cancer therapy used in treating certain blood disorders. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $29,807.56 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials on September 5, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by September 26, 2025, with performance based in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment, reflecting the Defense Logistics Agency's Medical Supply Chain's responsibility for procuring...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $149,037.80 and a firm fixed price structure. This contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $1 billion vehicle valued through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Jemperli (venetoclax) 500 mg/10 mL vials. This $22,355.67 firm fixed-price delivery order carries an ultimate completion date of October 15, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.8K to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries a firm fixed-price structure, with an ultimate completion date of September 23, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $14,903.78. This is a firm fixed price delivery order under a child contract with no set-aside designation, requiring performance and completion by August 29, 2025. The drug will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $119,230.24 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, particularly supporting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,903.78 on April 24, 2025, for the supply of JEMPERLI 500 mg/10 ml vials. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 15, 2025. The award is funded by the Department of Defense through its Medical Supply Chain organization and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with a ceiling value of $22,355.67 and an ultimate completion date of September 16, 2025. The contract represents a non-competitive set-aside award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...